In-office Placement of Mometasone Furoate Sinus Implants for Recurrent Nasal Polyps: A Pooled Analysis.

Autor: Stolovitzky JP; 1 ENT of Georgia, Atlanta, Georgia., Kern RC; 2 Department of Otolaryngology - Head and Neck Surgery at Northwestern University, Feinberg School of Medicine, Chicago, Illinois., Han JK; 3 Divisions of Rhinology and Endoscopic Sinus - Skull Base Surgery and Allergy, Eastern Virginia Medical School, Norfolk, Virginia., Forwith KD; 4 Advanced ENT and Allergy, Louisville, Kentucky., Ow RA; 5 Sacramento ENT, Roseville, California., Wright SK; 6 Iowa ENT Center, Des Moines, Iowa., Gould A; 4 Advanced ENT and Allergy, Louisville, Kentucky., Matheny KE; 7 Collin County Ear Nose and Throat, Frisco, Texas., Karanfilov B; 8 Ohio Sinus Institute, Dublin, Ohio., Huang S; 9 Palo Alto, California., Stambaugh JW; 10 Intersect ENT, Inc., Menlo Park, California., Gawlicka AK; 10 Intersect ENT, Inc., Menlo Park, California.

Publikováno v: American journal of rhinology & allergy [Am J Rhinol Allergy] 2019 Sep; Vol. 33 (5), pp. 545-558. Date of Electronic Publication: 2019 May 23.

A phase 3 trial of mometasone furoate sinus implants for chronic sinusitis with recurrent nasal polyps.

Autor: Kern RC; Northwestern University, Chicago, IL., Stolovitzky JP; ENT of Georgia, Atlanta, GA., Silvers SL; Madison ENT & Facial Plastic Surgery, New York, NY., Singh A; George Washington Medical Faculty Associates, Washington, DC., Lee JT; Orange County Sinus Institute, Southern California Permanente Medical Group, Irvine, CA.; Department of Head and Neck Surgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA., Yen DM; Bethlehem ENT, Bethlehem, PA., Iloreta AMC Jr; Mount Sinai Hospital, New York, NY., Langford FPJ; Charlotte Eye ENT Associates, Concord, NC., Karanfilov B; Ohio Sinus Institute, Dublin, OH., Matheny KE; Collin County Ear Nose & Throat, Frisco, TX., Stambaugh JW; Intersect ENT Inc., Menlo Park, CA., Gawlicka AK; Intersect ENT Inc., Menlo Park, CA.

Publikováno v: International forum of allergy & rhinology [Int Forum Allergy Rhinol] 2018 Apr; Vol. 8 (4), pp. 471-481. Date of Electronic Publication: 2018 Jan 19.

RESOLVE: bioabsorbable steroid-eluting sinus implants for in-office treatment of recurrent sinonasal polyposis after sinus surgery: 6-month outcomes from a randomized, controlled, blinded study.

Autor: Forwith KD; Advanced ENT and Allergy, Louisville, KY., Han JK; Divisions of Rhinology and Endoscopic Sinus-Skull Base Surgery and Allergy, Eastern Virginia Medical School, Norfolk, VA., Stolovitzky JP; ENT of Georgia, Atlanta, GA., Yen DM; Bethlehem Ear, Nose and Throat Associates, Bethlehem, PA., Chandra RK; Rhinology, Sinus and Skull Base Surgery, Department of Otolaryngology, Vanderbilt University, Nashville, TN., Karanfilov B; Department of Otolaryngology, Ohio State University, Ohio Sinus Institute, Dublin, OH., Matheny KE; Collin County Ear Nose and Throat, Frisco, TX., Stambaugh JW; Clinical Affairs, Intersect ENT, Menlo Park, CA., Gawlicka AK; Clinical Affairs, Intersect ENT, Menlo Park, CA.

Publikováno v: International forum of allergy & rhinology [Int Forum Allergy Rhinol] 2016 Jun; Vol. 6 (6), pp. 573-81. Date of Electronic Publication: 2016 Mar 14.

Safety and efficacy of a novel bioabsorbable, steroid-eluting sinus stent.

Autor: Murr AH; University of California, San Francisco School of Medicine, San Francisco, CA, USA. ahmurr@ohns.ucsf.edu, Smith TL, Hwang PH, Bhattacharyya N, Lanier BJ, Stambaugh JW, Mugglin AS

Publikováno v: International forum of allergy & rhinology [Int Forum Allergy Rhinol] 2011 Jan-Feb; Vol. 1 (1), pp. 23-32. Date of Electronic Publication: 2011 Feb 08.